BioCryst Pharma Inc (BCRX) Coverage Initiated By JP Morgan With Overweight

BioCryst Pharmaceuticals, Inc. (BCRX) was initiated with a ‘Overweight’ and it was given a $20.00 price target at JP Morgan (JPM) in a research report issued to clients on Friday. The prior close was $13.03, but the stock is sliding in premarket hours, trading down 1% at $12.90. That leaves close to 51% upside from […] View the full post at: BioCryst Pharma Inc (BCRX) Coverage Initiated By JP Morgan With Overweight Related posts: Pre-Market Earnings (April 28) Pre-Market Earnings (May 3) CenturyTel and Qwest Merger Off to a Rocky Start